CABA Stock Analysis: Buy, Sell, or Hold?
CABA - Cabaletta Bio, Inc. Common Stock
$3.21
-0.10 (-3.02%)
▼
5d:
-15.97%
30d:
-6.69%
90d:
+8.45%
WAIT
LOW Confidence
Analysis Updated: May 15, 2026 12:00 AM ET
Earnings: May 20, 2026
1d
Smart Money Accumulation
CABA is down 14.7% this week, but smart money is accumulating calls. Top strike: $4 2026-06-18 with 1,853 OI. Call ratio: 82% View Scanner →
Strength: 10.0/10
Get Alerted When CABA Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
10 traders called CABA this week
90% bullish • 2 bearish
90% bullish • 2 bearish
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
⏸️ WAIT FOR STABILIZATION: CABA is down 16.0% over the last 5 days. While fundamentals may be solid, catching a falling knife is risky. Wait for price to stabilize before entering.
⏸️ WAIT FOR STABILIZATION: CABA is down 16.0% over the last 5 days. While fundamentals may be solid, catching a falling knife is risky. Wait for price to stabilize before entering.
In-depth Analysis How we analyze
Valuation Analysis: CABA is currently trading at $3.21, which is considered fair relative to its 30-day fair value range of $2.99 to $3.72.
Technical Outlook: Technically, CABA is in a strong uptrend. The price is currently testing key support at $3.18. A bounce from this level would confirm strength, while a break below could signal further downside. Short-term momentum is weak, with the stock down 3.0% recently.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $13.12 (+296.5%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, CABA is in a strong uptrend. The price is currently testing key support at $3.18. A bounce from this level would confirm strength, while a break below could signal further downside. Short-term momentum is weak, with the stock down 3.0% recently.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $13.12 (+296.5%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
FAIR
Historical Trading Range
$2.99 -
$3.72
Company Quality Score
53/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
69.5%
All Signals
- NEUTRAL: Price in fair range
- NEUTRAL: Mixed technical signals (40/100)
- BULLISH: High volume confirmation
- BEARISH: Downward momentum (-3.0%)
- BULLISH: Trading 296.5% below Wall St target ($13.12)
- WARNING: Recommendation downgraded due to -16.0% 5-day decline - wait for stabilization
Trading Range Analysis
30-Day Trading Range
$2.99 -
$3.72
Current vs Trading Range
FAIR
Support & Resistance Levels
Support Level
$3.18
Resistance Level
$4.23
Current Trend
Strong Uptrend
Technical data as of
May 18, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-2.36
Wall Street Target
$13.13
(+296.5%)
Share & Embed Analysis
Last updated: May 18, 2026 1:15 PM ET
Data refreshes hourly during market hours. Next update: 2:15 PM
Data refreshes hourly during market hours. Next update: 2:15 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is CABA showing a specific setup today?
Insider Activity (6 Months)
7
Buys
0
Sells
+
Net
INSIDERS BUYING
Recent Transactions
David J Chang
BUY
8800 shares
2026-01-21
Gwendolyn Binder
BUY
11312 shares
2026-01-21
Mark Simon
BUY
11061 shares
2026-01-21
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
VRTX
Vertex Pharmaceuticals I… |
BUY
34 analysts |
$549 | 65 BUY |
|
LEGN
Legend Biotech Corp |
STRONG BUY
22 analysts |
$55 | 57 HOLD |
|
REGN
Regeneron Pharmaceutical… |
STRONG BUY
25 analysts |
$875 | 53 HOLD |
|
XENE
Xenon Pharmaceuticals Inc |
STRONG BUY
19 analysts |
$79 | 56 HOLD |
|
VKTX
Viking Therapeutics Inc |
STRONG BUY
19 analysts |
$92 | 54 HOLD |
